San Diego, CA, September 27, 2017 – Agena Bioscience today announced a comparative study published in PLOS ONE highlighting the use of its mass spectrometry-based
TrakCel Solution will electronically link Iovance with clinical sites, contract manufacturing organizations and couriers to schedule and track TIL therapies for each patient SAN CARLOS,
TrakCel solution integration with Cell and Gene Therapy Catapult manufacturing centre enables needle-to-needle supply chain management at any scale London, UK, September 7, 2017 –
Seattle, WA, August 24, 2017 – RareCyte, Inc., a global rare cell detection and liquid biopsy company will use the funding to advance its commercial
San Diego–(BUSINESS WIRE)—August 24, 2017– Illumina Inc. (NASDAQ: ILMN) today announced plans with Telegraph Hill Partners (THP), a San Francisco-based venture capital and growth equity
San Diego, CA, August 2, 2017– Agena Bioscience has entered into a 3-year agreement with the Illinois Department of Public Health (IDPH) which will deploy
AUSTIN, Texas–(BUSINESS WIRE)– Asuragen, Inc., a molecular diagnostics company changing the way diagnostics impact patient care in genetics and oncology, announced today the availability of
SAN DIEGO, Calif., June 29, 2017– Agena Bioscience today announced the European launch of the MassARRAY® System with CHIP Prep Module (CPM), marketed as a
MassARRAY® System Selected for Assurex Health’s GeneSight Test SAN DIEGO, Calif., June 20, 2017– Agena Bioscience today announced that Assurex Heath, a wholly owned subsidiary
Published on 15th June 2017 Magstim Group, Inc., the pioneer in trans-cranial magnetic stimulation and intraoperative nerve monitoring, today announced that it has appointed Lothar
Dynex Technologies (Dynex) has been acquired by Telegraph Hill Partners (THP), a leading venture capital and growth equity firm dedicated to the life science and
SAN DIEGO, Calif., March 15, 2017 — Agena Bioscience today introduced new targeted research panels for the detection of somatic mutations from lung and colon
10 / 1210

This website uses cookies to enhance your browsing experience and ensure the site functions properly. By continuing to use this site, you acknowledge and accept our use of cookies.

Accept All Accept Required Only